Meridian Life Science, Inc.

You’re invited to join our newsletter! “Diagnostics Dialogue”: where our experts come together to explore the latest trends, breakthroughs, and products in the field –- each edition is curated to keep you at the forefront of advancements in diagnostics. Click here to subscribe: https://hubs.la/Q035KNWl0 #newsletter #Meridian #newsworthy

Meridian’s universal Inhibitor-Tolerant qPCR/RT-qPCR master mixes (MDX013/MDX016) are ready-to-use super mixes designed for amplification from crude lysates or inhibitor-rich samples such as urine, CSF, blood, sputum, saliva, and stool. They offer: • Direct detection without extraction • High reproducibility and inhibitor tolerance • Robust detection with limited sample input • Sensitive and specific multiplex detection Ideal commercial applications include cancer detection assays (e.g. liquid biopsy), multiplex assays for antimicrobial resistance, point-of-care applications, and veterinary tests from crude samples. To learn more, visit: https://hubs.la/Q035KM2y0 #qpcr #molecularassays #inhibitortolerant #liquidbiopsy

Specialized enzymes that reduce time-to-results yet offer improvements in assay sensitivity and specificity are in high demand. Glycerol-free and lyo-compatible enzyme formulations are designed to offer 3 key advantages: 1. Ability to Lyophilize: facilitating easy ambient shipment and storage 2. Improved Activity and Stability: can be integrated into automated processes for operational efficiency 3. Ideal for Point-of-Care: better fluid dynamics for small-volume pipetting (e.g. microfluidic devices) Meridian has a range of glycerol-free enzymes, including taq polymerases, Bst, Pfu, MMLV-RT and a T7 RNA polymerase. To learn more, visit: https://hubs.la/Q035xjMq0 #lyophilization #moleculardiagnostics #poct #glycerolfree

Elevate your NGS capabilities with Meridian's pioneering Lyophilized NGS Library Prep Kit (MDX219-A), designed to simplify the NGS workflow and eliminate the need for cold-chain storage. Click here to learn more: https://hubs.la/Q035lNzZ0 #next-generationsequencing #sustainableinnovation

Cancer continues to be a global health challenge, with an estimated 20 million new cases and 9.7 million deaths in 2022. Early detection through regular screening remains critical for improving survival rates. Liquid biopsy is transforming cancer diagnostics, offering a non-invasive alternative to traditional tissue biopsy. By analyzing circulating tumor DNA (ctDNA) and other biomarkers in blood, urine, saliva, and stool, liquid biopsy provides a safer, repeatable, and highly informative approach to cancer screening and monitoring. However, selecting the appropriate technology is crucial for accurate and efficient liquid biopsy analysis. Both qPCR and NGS play vital roles in detecting and monitoring cancer: • qPCR – Ideal for fast, cost-effective detection of known mutations, making it a reliable choice for routine screening and targeted testing • NGS – Essential for comprehensive genomic profiling, detecting novel variants, and enabling personalized cancer treatment strategies As the demand for precision medicine grows, combining qPCR’s speed with NGS’s depth of analysis creates a more holistic approach to cancer diagnostics, ensuring both efficiency and comprehensive genetic insights. Want to learn more? Discover the latest advancements in PCR and NGS that are enhancing molecular diagnostics for applications such as liquid biopsy. Read our latest blog: https://hubs.la/Q035f7pG0? #LiquidBiopsy #CancerScreening #PrecisionMedicine #NGS #qPCR #MolecularDiagnostics

Enhance your high-throughput assays with Meridian's ultrapure dNTPs, synthesized in large scale from premium quality raw materials with hundreds of liters available now. They are >99% pure by HPLC, free from DNases, RNases and Nickases and they maintain exceptional stability for over 24 months. Ideal for PCR, qPCR, RT-PCR, cDNA synthesis, NGS, isothermal amplification, hi-fidelity and long-range PCR. Click here to learn more: https://hubs.ly/Q0358gjJ0 #moleculardiagnostics #dntp #nucleotides

Detecting a single cancer cell among millions of normal cells requires unparalleled sensitivity—driving the need for high-performance NGS technologies in circulating tumor DNA (ctDNA) detection. Stay ahead in MRD assay development with our cutting-edge NGS enzyme solutions: • Enhanced Sensitivity & Specificity – Achieve high-quality libraries from low-input and complex samples • Streamlined Workflow – Simplify library prep while maximizing sequencing accuracy • Reliable & Reproducible Results – Ensure consistent performance across diverse sample types • Optimized Performance – Maximize yields, minimize errors, and improve downstream analysis • Glycerol-Free Formulation – Improve stability, automation readiness, and high-throughput efficiency Contact us to learn how our advanced NGS solutions can support your MRD assay development: https://hubs.la/Q0353_MF0 #LiquidBiopsy #MRD #NGS #CancerDiagnostics #PrecisionMedicine

Sustainable practices aren’t just good for the environment—they’re a smart business strategy. For diagnostic companies, optimizing resource efficiency not only reduces carbon emissions but also lowers costs, enhances resilience, and drives competitive advantage. How can you make your assays more sustainable? Learn the key strategies to improve efficiency and minimize waste in diagnostic testing. Read our blog "Four Key Strategies to Enhance Sustainability in Diagnostic Testing": https://hubs.la/Q034-D1g0 #GreenDiagnostics #Sustainability #MolecularDiagnostics #AnimalFree

In recent years, genetic sequencing has emerged as a powerful tool in healthcare, offering insights into our genetic makeup and predispositions to various diseases. However, there is a stark disparity in the availability and accessibility of genetic testing globally. The current genomic data available lacks representation and fails to capture the genetic diversity that exists across different ethnicities and geographical regions. Read the blog “Bridging the Divide: Democratizing Genomic Testing by Lowering the Barriers to DNA Sequencing” to learn about the logistical barriers in democratizing next-generation sequencing (NGS) and the latest advancements in NGS reagent solutions that help to overcome these challenges and bridge the gap by eliminating the need for cold-chain shipping and storage. Click here to read the blog: https://hubs.la/Q034QFBr0 #nextgenerationsequencing #genomics #ngs #moleculardiagnostics #cancerscreening

LAMP is a popular technique for POCTs as the technology offers the same sensitivity and specificity as qPCR, while maintaining a short assay time and simplified assay design that enables greater portability. Meridian's Lyo-Ready DNA LAMP and RNA/DNA LAMP Mixes are the market-leading solution for POC assays with superior specificity and time-to-results (TTR). In addition, they incorporate Meridian’s Lyo-ready technology which can be used to create ambient-temperature stable assays ideal for POCTs. Click here to learn more:https://hubs.la/Q034Q2Vc0 #moleculardiagnostics #pointofcaretesting #isothermalamplification